BioNTech Statistics
NASDAQ: BNTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
95.25-0.48 (-0.50%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BioNTech by the numbers
BioNTech has a market capitalization of $23.93 billion based on 251.20M shares outstanding. With trailing EPS of $-7.83, BioNTech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.6% below its 50-day average and 2.6% below its 200-day average.
Average daily trading volume is 1.16M shares, or about $110.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BNTX valuation vs. peer median
| Metric | BNTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $23.93B | $11.97B | +100% |
| Avg. volume | 1.16M | 2.05M | -43% |
Peer median across 8 companies: BIIB, NBIX, EXEL, HALO, TECH, RGEN, IBRX, TWST.
Valuation
- Market cap
- $23.93B
- EPS (TTM)
- $-7.83
- Shares outstanding
- 251.20M
Price and trading
- Previous close
- 95.73
- Open
- 94.46
- Day range
- 93.92 – 97.46
- 52-week range
- 79.52 – 124.00
- 52-week change
- -10.19%
- Beta
- —
- Volume
- 827.75K
- Average volume
- 1.16M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 23.93B
- Forward Pe
- -17.23
- Eps
- -7.83
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 124.00
- Week52 Low
- 79.52
- Avg Volume
- 1.16M
- Shares Outstanding
- 251.20M
- Ma50
- 98.78
- Ma200
- 97.75
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -23.19%
- Pct From52w Low
- 19.78%